Hello, Fool! | Login | Signup | My Fool
Nov 21, 2008 1:29 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
View All Commentary (CELG)
Recs
pcmiller2 (< 20) Submitted: 11/20/07 3:44 PM : Start Price: $64.56 CELG Score: 26.68
long term uptrend in tact and at current price (63) close to long-term support
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK